Atlas Trials

Refractory Leukemia

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Leukemia

RecordFirmDate
Solving Riddles Through Sequencing (NCT05046444)Munich Leukemia Laboratory2022-01-19
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML (NCT05305859)The First Affiliated Hospital of Xiamen University2022-01-12
Tegavivint for the Treatment of Relapsed or Refractory Leukemia (NCT04874480)M.D. Anderson Cancer Center2021-09-27
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571)National University Hospital, Singapore2021-09-08
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML (NCT04722952)The First Affiliated Hospital of Soochow University2021-05-01
Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies (NCT04684472)Liqun Zou2021-03-17
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (NCT05164042)Shenzhen University General Hospital2021-02-05
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients (NCT04597086)Ohio State University Comprehensive Cancer Center2020-09-14
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy (NCT04282811)Gruppo Italiano Malattie EMatologiche dell'Adulto2020-07-24
Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia (NCT03799224)Peking University People's Hospital2018-12-01
Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) (NCT00880269)Novartis Pharmaceuticals2009-08-01

Track Refractory Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.